Table 2 Predictors of WHOQoL-HIV BREF component 12 weeks after DAA treatment

Male gender

2.56 (0.91–7.22)

0.050

4.01 (1.09–14.74)

0.037

0.86 (0.57–1.29)

0.677

1.12 (0.52–2.40)

0.992

1.49 (0.52–4.28)

0.559

1.36 (0.57–3.30)

0.654

Age ≤ 40 year

1.02 (0.69–1.52)

1.000

1.09 (0.78–1.53)

0.735

1.50 (0.85–2.63)

0.203

1.88 (0.83–4.26)

0.130

0.84 (0.48–1.48)

0.702

0.93 (0.57–1.52)

0.918

University education

0.84 (0.58–1.23)

0.462

0.96 (0.71–1.29)

0.901

0.84 (0.53–1.34)

0.581

0.71 (0.40–1.25)

0.306

1.07 (0.67–1.70)

0.911

Married versus not married

1.50 (0.69–3.26)

0.407

0.83 (0.39–1.79)

0.334

1.06 (0.47–2.42)

0.496

0.97 (0.42–2.25)

0.604

1.05 (0.47–2.35)

0.529

Married versus Widow/divorce

1.71 (0.65–4.50)

0.407

0.48 (0.18–1.29)

0.334

0.59 (0.23–1.53)

0.496

1.77 (0.54–5.77)

0.604

1.86 (0.62–5.53)

0.529

Regular worker versus non-regular

0.57 (0.28–1.17)

0.127

0.62 (0.29–1.31)

0.215

1.25 (0.62–2.55)

0.735

1.13 (0.54–2.34)

0.933

1.46 (0.66–3.22)

0.383

1.90 (0.89–4.08)

0.249

1.99 (0.89–4.44)

0.094

Regular worker versus not working

1.45 (0.52–4.06)

0.127

0.77 (0.23–2.56)

0.663

0.90 (0.33–2.41)

0.735

0.96 (0.35–2.65)

0.933

2.14 (0.64–7.17)

0.383

1.45 (0.52–4.06)

0.249

1.20 (0.41–3.58)

0.738

CD4 > 500 versus 350–500

1.47 (0.57–3.82)

0.636

0.71 (0.28–1.81)

0.772

1.04 (0.39–2.79)

0.944

0.65 (0.24–1.80)

0.787

0.75 (0.28–1.99)

0.882

CD4 > 500 versus < 350

0.79 (0.37–1.72)

0.636

0.77 (0.35–1.67)

0.772

0.82 (0.37–1.85)

0.944

0.71 (0.30–1.69)

0.787

0.79 (0.35–1.80)

0.882

HCV-RNA > 800,000 IU/mL

1.02 (0.66–1.57)

1.000

1.04 (0.73–1.49)

0.992

0.87 (0.53–1.44)

0.749

0.55 (0.32–0.93)

0.054

0.42 (0.18–0.94)

0.035

0.67 (0.42–1.08)

0.177

0.59 (0.25–1.38)

0.225

Interferon failure

1.03 (0.56–1.91)

1.000

0.54 (0.24–1.24)

0.132

0.34 (0.10–1.15)

0.083

0.42 (0.12–1.54)

0.220

0.36 (0.07–1.80)

0.215

1.16 (0.49–2.75)

0.748

0.92 (0.39–2.16)

1,000

Achieving SVR12

1.60 (0.49–5.23)

0.460

1.29 (0.54–3.06)

0.702

0.58 (0.29–1.16)

0.234

0.27 (0.05–1.45)

0.130

1.93 (0.31–12.07)

0.675

1.17 (0.35–3.85)

1,000

Non-smoker

0.92 (0.64–1.33)

0.796

0.81 (0.60–1.09)

0.214

0.65 (0.33–1.26)

0.197

0.62 (0.39–0.99)

0.234

0.46 (0.23–0.95)

0.035

1.18 (0.69–2.03)

0.671

0.46 (0.28–0.77)

0.003

0.32 (0.15–0.66)

0.002

BMI normal versus underweight

0.71 (0.27–1.91)

0.001

0.75 (0.28–2.03)

0.572

0.63 (0.23–1.72)

0.554

0.70 (0.26–1.90)

0.685

0.60 (0.22–1.64)

0.108

0.56 (0.20–1.57)

0.274

0.70 (0.26–1.90)

0.778

BMI normal versus overweight/obese

4.99 (1.88–13.19)

0.001

4.80 (1.79–12.81)

0.002

1.17 (0.53–2.57)

0.554

0.76 (0.33–1.72)

0.685

2.32 (0.81–6.65)

0.108

2.37 (0.81- 6.90

0.114

0.98 (0.42–2.27)

0.778

Non-IVDU

0.67 (0.32–1.42)

0.373

0.91 (0.54–1.52)

0.908

0.70 (0.29–1.69)

0.571

0.92 (0.38–2.25)

1,000

0.94 (0.44–2.02)

1,000

Fibrosis stage F0–F1 versus F2–F3

1.09 (0.47–2.51)

0.982

1.01 (0.44–2.34)

0.506

0.69 (0.29–1.62)

0.631

1.06 (0.40–2.83)

0.323

1.67 (0.64–4.35)

0.332

Fibrosis stage F0–F1 versus F4

1.02 (0.44–2.38)

0.982

1.63 (0.70–3.80)

0.506

0.75 (0.31–1.80)

0.631

0.53 (0.22–1.30)

0.323

0.72 (0.30–1.71)

0.332

Non-anemia

1.30 (0.74–2.26)

0.451

1.29 (0.81–2.06)

0.349

0.95 (0.53–1.69)

1.000

1.15 (0.54–2.44)

0.912

1.22 (0.62–2.40)

0.717

NNRTI-based versus PI-based ART

1.07 (0.61–1.88)

0.993

1.34 (0.77–2.32)

0.360

3.62 (0.96–13.68)

0.036

5.23 (1.16–23.65)

0.032

1.81 (0.62–5.30)

0.371

2.26 (0.78–6.56)

0.145

3.26 (0.87–12.18)

0.078